CCL19 and neoplasm: Perhaps the most compelling evidence that tumor-derived chemokines influence the type of DCs found in the tumor has been demonstrated in a renal-cell carcinoma model (52), where the intra-tumoral or peri-tumoral distribution of DCs is determined by CCL20 and CCL19 levels.